Medtech titan Medtronic (NYSE:MDT) found itself the target of yet another shareholder lawsuit, lodged over complaints associated with the company’s long-troubled Infuse bone morphogenetic protein.
Legal News
ArthroCare, Justice Dept. ink 4th extension
For the 4th time in a year, ArthroCare and the Justice Department extended their deadline to strike a deal in an ongoing criminal probe into the company’s spinal business unit.
The Austin, Tex-based company and the DOJ entered into another tolling agreement, a deal that extends statute of limitation rules, until August 31st. The negotiations were 1st extended in January, and the most recent tolling agreement was set to close May 31.
Women’s health: Smith & Nephew win over Hologic stands, damages TBD
Federal Circuit again invalidates Cordis patent claims against Medtronic, Abbott, Boston Sci.
A trio of medical device giants notched another win against Johnson & Johnson(NYSE:JNJ) after a Federal Circuit judge upheld a lower court’s ruling that invalidated stent patents held by J&J subsidiary Cordis Corp.
Hip implant lawsuits: DePuy moves to bar testimony of 2 experts from previous trial
FLASH: SEC charges Imaging3 and CEO Dean Janes with fraud
Pelvic mesh lawsuits: Internal Bard memo shows medical device company knew mesh was unfit for humans
Minnesota feds probe Medtronic over Trade Agreements Act
Medtronic (NYSE:MDT) said the U.S. Attorney’s office for Minnesota wants to see documents showing the medical device company’s compliance with the Trade Agreements Act.
Federal authorities in the Land of 10,000 Lakes sent a letter May 6 to Fridley, Minn.-based Medtronic requesting the information, according to a regulatory filing.
NuVasive reiterates 2013 sales guidance
Abiomed conquers shareholder’s lawsuit over Impella claims
Endo Health’s American Medical Systems to settle mesh lawsuits for $55M
Endo Health Solutions (NSDQ:ENDP) subsidiary American Medical Systems said it’s agreed to pay $54 million to settle personal injury lawsuits filed over its pelvic mesh products.